Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Management of Hip and Knee Osteoarthritis in Primary Health Care

30 de enero de 2018 actualizado por: Nina Osteras, Diakonhjemmet Hospital

Improved Management of Patients With Hip and Knee Osteoarthritis in Primary Health Care

Previous research has shown that the osteoarthritis care for persons with hip or knee osteoarthritis in Norway has a potential for improvement as the provided care may not necessarily reflect evidence-based guideline recommendations. This study will determine if a new model for integrated osteoarthritis (OA) care in primary health care will result in improved quality of osteoarthritis care and health benefits for the patients (reduced pain and body weight, increased function and activity level) among patients with hip and/or knee osteoarthritis. Further, this study will examine if the new model reduce the number of unnecessary referrals to Magnetic Resonance Imaging (MRI) and to orthopaedic surgeons in secondary care, and if it increases the number of referrals to physiotherapy treatment and the number of discharge reports from the physiotherapists to the referring general practitioner.

Descripción general del estudio

Estado

Terminado

Intervención / Tratamiento

Descripción detallada

A new model for integrated care for patients with hip and/or knee osteoarthritis (OA) in primary care will be developed and implemented. The purpose of the model is to improve quality of OA care in primary health care services by increasing the collaboration between health care professionals and across health care levels, providing an integrated care and a patient pathway, and facilitating an active and healthy lifestyle among individuals with OA. This implementation study represents a collaborative study between six municipalities and a hospital department aiming to fulfill the intentions of the Norwegian Health Care Coordination Reform. The main aim of the present study is to implement and perform process and effect evaluations of this new model for integrated OA care. The study design will be a cluster randomized controlled trial with a stepped wedge design. Six neighboring municipalities will constitute the six clusters, which will switch from control (current OA care) to intervention phase (new OA model) in a randomized order. All municipalities start the trial simultaneously and act as controls until the point in time they are randomized to crossover from control to intervention, and all municipalities have implemented the intervention by the end of inclusion. The method consists of two parts; 1) Identification of barriers/facilitators + development of the model and interventions, 2) Implementation of the new model (interactive workshops) with process and effect evaluations. Participants will be general practitioners and physiotherapists in primary care as well as people with hip or knee OA.

Tipo de estudio

Intervencionista

Inscripción (Actual)

393

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

      • Oslo, Noruega, 0319
        • Diakonhjemmet Hospital

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

45 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Activity-related hip and/or knee pain/complaints AND
  • Clinical signs and symptoms corresponding to hip and/or knee OA OR radiologically diagnosed OA OR Registered in the medical journal with the ICPC codes L89 (osteoarthritis of the hip), L90 (osteoarthritis of knee), L91 (osteoarthritis not classified elsewhere), L13 (hip symptoms/complaints), L15 (knee symptoms/complaints) and/or L20 (joint symptoms/complaints not classified elsewhere).

Exclusion Criteria:

  • Total hip or knee replacement in the actual joint(s) and no pain/complaints in the other hip or knee joint(s)
  • Inflammatory rheumatic diseases (e.g. rheumatoid arthritis, spondyloarthritis)
  • Malignant illness or other major conditions (i.e unstable cardiovascular disorders or lung disease, dementia) that restrict the ability to adhere to the recommended OA treatment
  • Do not understand the Norwegian language

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Investigación de servicios de salud
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación cruzada
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Sin intervención: Control group
Usual care. The participants enrolled in the control period will receive OA treatment as it is currently offered in primary health care services.
Experimental: Intervention group
New OA model. Health professionals attend an interactive workshop, implementation of international recommendations for OA care, multidiciplinary collaboration
The general practitioners and the physiotherapists will attend an inter-active workshop and deliver osteoarthritis care in line with international recommendations for osteoarthritis treatment. The general practitioner will refer eligible patients to treatment by physiotherapists at "Healthy Living Center" or by physiotherapists in private practice. This treatment will include a standardized patient education program followed by structured exercise program with individual adjustments. The general practitioner will schedule a follow-up after the 12-week treatment and will receive a treatment report from the physiotherapist.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Osteoarthritis Quality Indicator questionnaire
Periodo de tiempo: 6 months
Patient reported achievement of quality indicators for osteoarthritis care
6 months

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Pain
Periodo de tiempo: 6 months
Pain level in hip/knee past week
6 months
Joint stiffness
Periodo de tiempo: 6 months
Stiffness in the hip/knee past week
6 months
Global function
Periodo de tiempo: 6 months
Hip/knee function in the past week
6 months
Patient global assessment of the OA disease
Periodo de tiempo: 6 months
6 months
Patient Acceptable Symptom State (PASS)
Periodo de tiempo: 6 months
6 months
Hip/knee function, quality of living subscale
Periodo de tiempo: 6 months
Function (Knee injury and Osteoarthritis Outcome Score ADL subscale/ Hip disability and Osteoarthritis Outcome Score OoL subscale (K/HOOS)
6 months
Physical activity level
Periodo de tiempo: 6 months
An index based on self-reported frequency, intensity, duration of physical activity
6 months
Daily sitting
Periodo de tiempo: 6 months
Daily hours in sitting position
6 months
Satisfaction with the care provided
Periodo de tiempo: 6 months
6 months
Health related quality of life (EQ-5D)
Periodo de tiempo: 6 months
6 months
Self-reported body weight
Periodo de tiempo: 6 months
6 months
Health care use, medication use and sick leave
Periodo de tiempo: 6 months
6 months
Adverse events
Periodo de tiempo: Up to 1 year
Up to 1 year
Health professionals' knowledge, attitude and behavior in OA care
Periodo de tiempo: Pre- and post-workshop + 6 months post-workshop
Pre- and post-workshop + 6 months post-workshop
Referrals to orthopaedic surgeons
Periodo de tiempo: Up to 1 year
Number of referrals to secondary care that does not lead to scheduled joint surgery
Up to 1 year
Referrals to MRI
Periodo de tiempo: Up to 1 year
Number of referrals to MRI for OA assessment
Up to 1 year
Number of referrals to physiotherapy treatment
Periodo de tiempo: Up to 1 year
Up to 1 year
Discharge reports from physiotherapists
Periodo de tiempo: Up to 1 year
Number of discharge reports from PTs at FLSs/ private practice to the referring GP
Up to 1 year
Arthritis Self-efficacy Scale
Periodo de tiempo: 6 months
6 months

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Investigadores

  • Director de estudio: Kåre Hagen, Prof., Project administrator/Research director
  • Investigador principal: Nina Østerås, PhD, Researcher

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio

1 de enero de 2015

Finalización primaria (Actual)

1 de octubre de 2017

Finalización del estudio (Actual)

1 de octubre de 2017

Fechas de registro del estudio

Enviado por primera vez

4 de enero de 2015

Primero enviado que cumplió con los criterios de control de calidad

5 de enero de 2015

Publicado por primera vez (Estimar)

7 de enero de 2015

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

1 de febrero de 2018

Última actualización enviada que cumplió con los criterios de control de calidad

30 de enero de 2018

Última verificación

1 de enero de 2018

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • 229079

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Ensayos clínicos sobre New OA model

3
Suscribir